Evaluation of the Effects of a Novel Dietary Microalgae Based Ingredient on Muscle Recovery and Endurance Capacity
PORPHY-ONE
Evaluation of the Protective Effects of a Novel Dietary Microalgae Supplement (PeLiv) Following Exercise-induced Muscle Damage and Influence on Endurance Capacity After Prolonged Consumption
1 other identifier
interventional
80
1 country
1
Brief Summary
The purpose of this investigation is to examine the effects of consuming a new dietary microalgae based supplement vs. placebo on neuromuscular function, energy utilization, soreness, perceptual wellness, swelling, and markers of muscle damage and inflammation in healthy young men before and after an acute exercise-induced muscle damage protocol (downhill running), and influence on endurance capacity after prolonged consumption.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable healthy
Started Jan 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 10, 2023
CompletedFirst Submitted
Initial submission to the registry
February 23, 2023
CompletedFirst Posted
Study publicly available on registry
March 8, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 18, 2023
CompletedSeptember 22, 2023
September 1, 2023
7 months
February 23, 2023
September 21, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Neuromuscular function
isokinetic peak torque in Newton per meter (N/m)
From 0 to week 4
Secondary Outcomes (17)
Energy utilization (Oxygen consumption - VO2)
From 0 to week 4
Energy utilization (Oxygen consumption - VO2)
From 0 to week 8
Isokinetic neuromuscular function
From 0 to week 8
Isometric neuromuscular function
From 0 to week 8
Endurance capacity
From 0 to week 4
- +12 more secondary outcomes
Study Arms (4)
Placebo group
PLACEBO COMPARATOR2 capsules of Maltodextrin per day
MicAlgae100
EXPERIMENTAL2 capsules per day containing 100mg of microalgae based ingredient
MicAlgae250
EXPERIMENTAL2 capsules per day containing 250mg of microalgae based ingredient
MicAlgae500
EXPERIMENTAL2 capsules per day containing 500mg of microalgae based ingredient
Interventions
Eligibility Criteria
You may qualify if:
- Male participants
- Healthy as assessed by Medical and activity history questionnaire (MHQ)
- Recreationally active according to American College of Sports Medicine guidelines
- Able to provide written and dated informed consent to participate in the study
You may not qualify if:
- Untrained
- Any response of "yes" on the PAR-Q+
- Physical limitations preventing running, countermovement jump, and strength (peak isometric torque and peak isokinetic torque) assessments
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Microphytlead
- University of Central Floridacollaborator
Study Sites (1)
University of Central Florida
Orlando, Florida, 32816, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David Fukuda, PhD
University of Central Florida
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 23, 2023
First Posted
March 8, 2023
Study Start
January 10, 2023
Primary Completion
August 1, 2023
Study Completion
August 18, 2023
Last Updated
September 22, 2023
Record last verified: 2023-09
Data Sharing
- IPD Sharing
- Will not share